Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,558 | 14,909 | 13,890 | 14,038 | 15,814 |
| TOTAL | $15,194 | $15,714 | $16,250 | $16,544 | $18,684 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 108 | 149 | 191 | 232 | 274 |
| TOTAL | $108 | $149 | $191 | $232 | $274 |
| Total Assets | $15,302 | $15,863 | $16,441 | $16,776 | $18,958 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 683 | 772 | 684 | 770 | 2,218 |
| TOTAL | $683 | $772 | $684 | $770 | $2,218 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $683 | $772 | $684 | $770 | $2,218 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,410 | 13,410 | 13,410 | 13,410 | 13,380 |
| Common Shares | 1,334 | 1,334 | 1,334 | 1,334 | 1,334 |
| Retained earnings | -545,617 | -545,092 | -544,333 | -543,637 | -542,529 |
| TOTAL | $14,619 | $15,091 | $15,757 | $16,006 | $16,740 |
| Total Liabilities And Equity | $15,302 | $15,863 | $16,441 | $16,776 | $18,958 |